DIMINISHED URINARY EXCRETION OF CYCLIC AMP BY RATS GIVEN DISODIUM ETHANE-1-HYDROXY-1,1-DIPHOSPHONATE

in Journal of Endocrinology
Authors:
AILSA GOULDING
Search for other papers by AILSA GOULDING in
Current site
Google Scholar
PubMed
Close
,
RUTH McCHESNEY
Search for other papers by RUTH McCHESNEY in
Current site
Google Scholar
PubMed
Close
, and
R. S. MALTHUS
Search for other papers by R. S. MALTHUS in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Department of Medicine and Biochemistry Research Group, University of Otago Medical School, Dunedin, New Zealand

(Received 7 October 1974)

High doses of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) inhibit bone mineralization, induce hypercalcaemia and diminish intestinal absorption of calcium in the rat (Gasser, Morgan, Fleisch & Richelle, 1973; Goulding & McChesney, 1974). This hypercalcaemia, either by a direct effect or by inhibiting secretion of parathyroid hormone (PTH), may suppress renal synthesis of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and hence explain the diminished intestinal absorption of calcium (Bonjour, DeLuca, Fleisch, Trechsel, Matejowee & Omdahl, 1973; Hill, Lumb, Mawer & Stanbury, 1973). Parathyroid hormone affects the renal production and excretion of cyclic AMP (Chase & Aurbach, 1967) and cyclic AMP enhances the synthesis of 1,25(OH)2D3 (Rasmussen, Wong, Bikle & Goodman, 1972; Larkins, MacAuley, Rapoport, Martin, Tullock, Byfield, Matthews & Maclntyre, 1974). Thus reduced production of cyclic AMP after administration of EHDP may be important in diminishing renal synthesis

 

  • Collapse
  • Expand